Author

B. X. Li

Jiangsu Academy of Agricultural Sciences

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Baochao FaniD· 1 shared Boshui Yuan· 1 shared Dewen TongiD· 1 shared Gen Li· 1 shared Guiwen GuaniD· 1 shared Haixin LiuiD· 1 shared Haolun TianiD· 1 shared Jianhui Zhong· 1 shared

Activity by Year

2022-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Baochao FanORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Coronavirus envelope protein drives iron sensing disorder by hijacking the TAp73-FDXR axis

Mingjun Zhu, Leyu Hu, Xingwei Fu, Boshui Yuan, Guiwen Guan, Lu Han, Zesheng Rong, Ru Tian, Gen Li, Muzi Du, Yan Ma, Ning Xu, Haixin Liu, Haolun Tian, Xinhuan Yin, , Dewen Tong

This study identifies how the coronavirus envelope protein disrupts the TAp73-FDXR axis to cause iron overload, leading to iron deficiency perception and tissue damage, and presents a therapeutic molecule to counteract this effect.

bioRxiv · Mar 25, 2026 · PreprintMicrobiology

PRMT5 as a Novel Druggable Vulnerability for EWSR1-ATF1-driven Clear Cell Sarcoma

B. X. Li, X. Xiao, L. L. David, L. E. Davis

This study identifies PRMT5 as a druggable target for EWSR1-ATF1-driven clear cell sarcoma, showing that its inhibition reduces tumor cell growth.

bioRxiv · Mar 23, 2022 · PreprintCancer Biology